Aihara Naoyuki, Ochiai Mariko, Horiuchi Noriyuki, Yamamoto Atsushi, Sudo Kasumi, Ishikawa Yoko, Oishi Koji
National Veterinary Assay Laboratory, Ministry of Agriculture, Forestry and Fisheries, 1-15-1 Tokura, Kokubunji, Tokyo 185-8511, Japan.
Laboratory of Veterinary Pathology, School of Veterinary Medicine, Azabu University, 1-17-71 Fuchinobe, Chuo-ku, Sagamihara, Kanagawa 252-5201, Japan.
J Vet Med Sci. 2019 Aug 24;81(8):1129-1132. doi: 10.1292/jvms.19-0058. Epub 2019 Jul 3.
Veterinary vaccines are subjected to a safety testing using laboratory animals via intraperitoneal injection per batch. From April 2010 to March 2011, 7 guinea pigs in 4 batch tests exhibited unrecoverable weight loss and/or were found dead. Six guinea pigs had developed intussusception, whereas another one had developed an intestinal obstruction consequent to adhesion. A histopathology revealed that these lesions were associated with inflammatory foci. Other animals than the 7 guinea pig also developed similar inflammatory foci but did not develop bowel disorders. In the retesting of these batches, animals did not exhibited clinical signs, though inflammatory foci were detected. The clinical signs, detected in the primary test, might be due to bowel disorders secondary to an inflammatory response, rather than toxicity.
每批兽用疫苗都要通过腹腔注射对实验动物进行安全性测试。在2010年4月至2011年3月期间,4批测试中的7只豚鼠出现了无法恢复的体重减轻和/或死亡。6只豚鼠发生了肠套叠,而另一只因粘连导致肠梗阻。组织病理学检查显示,这些病变与炎症灶有关。除7只豚鼠外的其他动物也出现了类似的炎症灶,但未出现肠道疾病。在对这些批次进行重新测试时,动物未表现出临床症状,尽管检测到了炎症灶。在初次测试中检测到的临床症状可能是由炎症反应继发的肠道疾病引起的,而非毒性所致。